Interferon is an important cytokine that plays a critical role in the initial host defense against viral infection. Recombinant human adenoviruses expressing human interferon-α (Ad-HIFNα) or pig interferon-β fused with interleukin-18 (Ad-PIFNβ-IL18) were constructed and used to induce an early protective response against foot and mouth disease (FMD). To analyze the antiviral effect, bovine thyroid and porcine kidney IBRS-2 cells and ICR mice were treated with Ad-HIFNα, Ad-PIFNβ-IL18, and cocktail of Ad-HIFNα and Ad-PIFNβ-IL18. The survival rate of suckling mice was monitored after foot and mouth disease virus (FMDV) challenge following intra-peritoneal (IP) administration of appropriate adenovirus. Indirect antigen ELISA was performed to evaluate inhibition of FMDV replication following challenge with the FMDV O, A, or Asia 1 serotypes in vitro. These recombinant adenoviruses reduced the replication of FMDV in susceptible cells, thereby decreasing the fatality in mice, suggesting that they can be a useful control method for the early protection against FMD infection in livestock after field trial.
INTRODUCTION
Foot and mouth disease (FMD) is a devastating disease in cattle, swine, sheep, goats, and many wild cloven-hoofed animal species. The causative agent of the disease belongs to the Aphthoviruses genus of the Picornaviridae family and has a positive sense, single-stranded RNA genome. This disease is characterized by temporary and debilitating oral and pedal vesicles (1) .
Despite the success of the inactivated vaccine development, a significant portion of FMD research has been focused on the development of novel vaccines which could be manufactured without the concern of virus mutation or the need for high-containment facilities (2) . Disease-free countries hesitate to use vaccination to eliminate FMD because the current vaccine contains varying degrees of contaminating viral non-structural (NS) proteins that make it difficult to differentiate infected from vaccinated animals.
In addition, the current vaccine requires 7~14 days for protection to fully develop. This concern is particularly relevant to the control of FMD since FMDV replicates and spreads so rapidly. Prior to induction of the adaptive immune response, animals are still susceptible to new infection. As Recent pharmacokinetic studies indicate that IFN exhibits an extremely short half-life in the blood after parenteral administration. The poor performance of IFNs may have been caused by an insufficient delivery or lack of sustained delivery of the protein to the active site (9) . Recently, delivery systems using adenovirus have been recommended as an effective therapeutic strategy to deliver genes and to express foreign protein in mammals (10~12). The use of adenovirus can induce mucosal immunity and stimulate an immune response in the respiratory and digestive systems (13, 14) . Furthermore, the advantages of the adenovirus expression system are its ability to infect various cell types and to deliver foreign genes for expression in host animals like cattle and pigs (15) . Adenovirus containing porcine IFNα (Ad-PIFNα) has been reported to be effective against FMDV infection (16) . It was well known that porcine IFNα had better anti-FMDV effect than IFNβ (4). Furthermore, bovine IFNα also had anti-FMDV effect (17) .
In this study, to induce an antiviral state in vivo, we used adenoviruses expressing IFNα or β. Anti-FMDV effects of human IFN has been questionable in porcine or bovineoriginated cells and animals. Therefore, we investigated the potential anti-FMDV effect of human IFN as the first line of defense in the animals. In addition, an adenovirus expressing porcine IFNβ and IL-18 was tested to cover the host-specific response for pig with use of human interferon. IL-18, a known inducer of IFNγ, was used for an additional effect by sustaining the delayed anti-viral state. The fused form for porcine cytokines would be effective as a defense strategy for one shot vaccine carrying function for double effects.
Cattle and pig cells, in vitro, and sucking mice were infected with the recombinant adenoviruses for the measurement of their antiviral activity and effect on FMDV replication. 
MATERIAL AND METHODS

Virus and cells
Construction of antiviral protein expressing recombinant adenoviruses
Five micrograms of adenoviral DNA (Q-BIO gene, CA, USA) and EcoR I-linearized pHIFNα and pPIFNβ-IL18 DNA were co-transfected by co-precipitation using calcium phosphate in HEK 293A cells. After 24 h, co-transfected cells were transferred to 6 well plates and overlaid with 2 
SDS-PAGE and Western blot analysis
For protein analysis, recombinant virus infected HEK 293A cells were prepared in lysis buffer and then disrupted by sonication. The clarified supernatant after centrifugation at 13,000 rpm for 10 min was used for 12% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE).
The electrophoresed proteins in a 12% SDS-PAGE gel were 
Challenge test against FMDV in suckling mice
All experimental animals were cared for according to the animal management guideline of QIA in Korea. Ten of 7 day-old suckling ICR mice per group were injected with Ad-HIFNα (10 6.5 TCID 50 /0.1 ml) and Ad-PIFNβ-IL18 (10 7.5 TCID 50 /0.1 ml). After 24 h, mice were injected with FMDV (10 to 125 LD 50 /0.1 ml) for challenge and their survival rate was observed for following 10 days postchallenge.
RESULTS
Effect of IFNα and IFNβ on FMDV replication
IBRS-2 cells were transfected with plasmids containing the antiviral genes HIFNα and PIFNβ-IL18 at various concentrations for comparison of antiviral effects. After 24
h, the cells were infected by FMDV (100 TCID 50 /0.1 ml).
After 48 h, the supernatant was harvested for FMDV antigen quantitation. The plasmid containing HIFNα gene (pHIFNα) showed a better anti-FMDV effect than pPIFNβ-PIL18 (Fig. 2) . The lower concentrations of pPIFNβ-IL18
had very little effect on FMDV replication, but a high concentration (1 μg) had a measurable antiviral effect. The plasmid mixture of pHIFNα and pPIFNβ-IL18 showed antiviral activity at the same level as pHIFNα. Both plasmids at a concentration of 1 or 2 μg showed strong anti-FMDV activities, but the pPIFNβ-IL18 at concentration of 3.9 ng to 0.5 μg could not inhibit FMDV replication (Fig. 2) .
Construction of recombinant adenoviruses expressing
IFNs and IL-18
The molecular weight of proteins expressed in HEK 293A cells was 25 kDa for Ad-HIFNα, and 53 kDa for Ad-PIFNβ-IL18, as determined by Western blot assay (Fig. 3) .
To identify inhibition of FMDV replication after recombinant adenovirus infection, FMDV antigen ELISA was performed using the supernatant collected 48 h after FMDV challenge following the adenovirus infection for 24 h in bovine thyroid or IBRS-2 cells. Ad-HIFNα showed strong antiviral effect as demonstrated using plasmid transfection (Fig. 4) . The contribution of the PIFNβ-IL18 appeared to be negligible.
Anti-FMDV effect in vivo
Suckling mice were infected with either Ad-HIFNα or Ad-PIFNβ-IL18. As shown in Fig. 5 , the group with recombinant adenovirus had a longer survival rate compared to the control group. The group of Ad-HIFNα or Ad-PIFNβ-IL18 showed extended survival of 2 days compared with control group (Fig. 5 and Fig 6) . Among the groups, 
